10-Year Data from the Medtronic ENGAGE OUS Registry is the First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of Durable Outcomes in Real-World Setting

The ENGAGE OUS registry evaluated more than 1,200 patients. The 10-year data, which included follow-up from approximately 400 of these patients, showed a 94.7 percent freedom from aneurysm-related mortality (ARM) † and 64.1 percent sac regression (or decreased AAA sac diameter) ‡ at 10 years.

Continue Reading10-Year Data from the Medtronic ENGAGE OUS Registry is the First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of Durable Outcomes in Real-World Setting